Caroline Baumal Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

Caroline Baumal is Chief Medical Officer of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 91,206 shares of APLS, which is worth approximately $1.85 Million. The most recent transaction as insider was on Jan 05, 2026, when has been sold 3,020 shares (Common Stock) at a price of $25.53 per share, resulting in proceeds of $77,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 91.2K

2.25% 3M change

64.16% 12M change

Total Value Held $1.85 Million

Caroline Baumal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 05 2026	SELL Open market or private sale	$77,100 $25.53 p/Share	3,020 Reduced 3.21%	91,206 Common Stock
Jan 21 2025	BUY Grant, award, or other acquisition	-	39,594 Added 29.79%	93,301 Common Stock
Jan 17 2025	SELL Open market or private sale	$55,515 $29.96 p/Share	1,853 Reduced 3.34%	53,707 Common Stock
Jan 06 2025	SELL Open market or private sale	$95,208 $33.81 p/Share	2,816 Reduced 4.82%	55,560 Common Stock
Jan 16 2024	BUY Grant, award, or other acquisition	-	25,445 Added 30.36%	58,376 Common Stock
Jan 04 2024	SELL Open market or private sale	$165,197 $60.05 p/Share	2,751 Reduced 7.71%	32,931 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	35,549 Added 49.91%	35,682 Common Stock

Caroline Baumal

Chief Medical Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Value

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS

Account